Back to search

Improved Cognition in Alzheimer’s Disease With Short-Term D-Cycloserine Treatment

Data up to Jan 2025

Published1999
Citations130
References16

Total Citations Per Year

Abstract

References (16)

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

Cerebral Blood Flow in Dementia

1975 • 3,133 citations

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1983 • 3,028 citations

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

1997 • 2,394 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

d-Cycloserine enhances implicit memory in Alzheimer patients

1996 • 150 citations

Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's Disease

1989 • 117 citations

Role of Glycine in the N‐Methyl‐d‐Aspartate‐Mediated Neuronal Cytotoxicity

1990 • 113 citations

Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease

1990 • 94 citations

Effects of NMDA Modulation in Scopolamine Dementiaa

1991 • 87 citations

Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia

1993 • 66 citations

d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain

1991 • 63 citations

D-Cycloserine Treatment of Alzheimer Disease

1994 • 53 citations

Evaluation of Cycloserine in the Treatment of Alzheimer's Disease

1995 • 49 citations

A Preliminary Study of<scp>d</scp>-Cycloserine Treatment in Alzheimer's Disease

1998 • 35 citations

Cognitive and Quantified Electroencephalographic Correlates of Cycloserine Treatment in Alzheimerʼs Disease

1995 • 28 citations

Cited By (0)

Loading...